Clinical trial Recruiting at 1 site Interventional Ages 3 to 6

Preventing early childhood myopia with special spectacle lenses and low-dose atropine

Official title: Project on Myopia Surveillance and Intervention Services for Preschool Children in Shanghai

Run by Shanghai Eye Disease Prevention and Treatment Center · NCT07176949 · Data updated 2026-11-12

This project will try spectacle lenses with highly aspherical lenslets and low-dose (0.01% and 0.05%) atropine eye drops to see if they slow myopia progression in children aged 3–6.

More Myopia trials

Quick facts

Study typeInterventional
Ages3 Years to 6 Years
SexAll
Enrollment508 (estimated)
SponsorShanghai Eye Disease Prevention and Treatment Center
Academic / other
Locations1 site (Shanghai, Shanghai Municipality)
StatusRecruiting
StartedJune 1, 2025
Main results expectedJune 1, 2027
Study endsMay 31, 2028
Registry record updatedSeptember 16, 2025
Trial IDNCT07176949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3–6 with early or pre-myopia (cycloplegic spherical equivalent up to +0.75 D), low astigmatism, good corrected visual acuity, and ability to wear spectacles and attend follow-up visits.

Probably not a fit

Children with strabismus, amblyopia, other ocular or systemic diseases affecting vision, or those who have recently used other myopia-control treatments are unlikely to benefit from enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Children aged 3–6 with early or pre-myopia will be enrolled and assigned to receive either spectacle lenses with highly aspherical lenslets or low-concentration atropine eye drops (0.01% or 0.05%). Vision and eye health, including cycloplegic refraction and other standard measures, will be monitored at regular visits to track refractive change and any side effects. Participants must be able to wear spectacles as required and attend follow-up visits at the study site. Outcomes will compare how much myopia progresses and the safety profile across the intervention groups.

Why it matters

Potential benefit: If successful, these interventions could slow progression to higher myopia in preschool children and reduce their lifetime risk of severe vision problems.

How similar studies have gone: Previous studies in older children have shown that defocus-type lenses and low-dose atropine can slow myopia, but evidence is limited for preschool-aged children.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 3-6 years, gender unrestricted;
* Bilateral cycloplegic spherical equivalent (SE) ≤ +0.75 D, astigmatism ≤-2.5 D, anisometropia ≤2.5 D;
* Best corrected visual acuity: ≥0.5 for ages 3-5, ≥0.7 for age 6;
* Accept regular follow-up, written informed consent from guardians, verbal informed consent from children;
* Possess normal thinking and language communication skills, and can actively cooperate to wear spectacles as required.

Exclusion Criteria:

* Existence of strabismus or amblyopia or other binocular vision abnormalities, accommodation dysfunction, cataract and history of eye surgery;
* Any ocular or systemic disease that may affect vision and refractive development (e.g., Keratoconus, Marfan syndrome, retinopathy of prematurity, etc.);
* Current or previous use of other treatments for myopia intervention, such as pharmacological (atropine) and optical (orthokeratology lenses or DIMS spectacle lenses) approaches, interrupt use for at least 4 weeks;
* Allergy or contraindication to cycloplegic drugs;
* Epilepsy or other mental disorders unable to expressing consent;
* Other conditions deemed unsuitable for participation by the researcher.

Where it's running

  • Shanghai Eye Disease Prevention and Treatment Center
    Shanghai, Shanghai Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.